A pan-cancer exploration of kinesin family member 20A (KIF20A)'s oncogenic activity in human tumors

Xiaojun Liu,Yiqun Du,Jian Zhang
DOI: https://doi.org/10.21203/rs.3.rs-1705038/v1
2022-01-01
Abstract:Abstract Background: Increasing evidence has revealed that kinesin family member 20A (KIF20A) is highly expressed in a variety of cancers and is related to the occurrence and prognosis of cancer. However, a pan-cancer analysis has not been performed.Methods and results: Based on data from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Clinical Proteomic Tumor Analysis Consortium (CPTAC) and Human Protein Atlas (HPA) databases, we clarified the expression of KIF20A in 33 tumor types using a series of bioinformatics analyses. KIF20A is highly expressed in the majority of malignancies, and there were distinct connections between KIF20A expression and pathological stage and prognosis in tumor patients. KIF20A overexpression was associated with poor overall survival (OS) and disease-free survival (DFS) in patients with certain cancers, such as adrenocortical carcinoma, kidney renal clear cell carcinoma and brain lower grade glioma. The associations of KIF20A expression with immune cell infiltration, including the levels of infiltrating B cells, T cells, and dendritic cells, varied among tumors. Moreover, we found a positive association between KIF20A expression and cancer-associated fibroblast infiltration in patients with esophageal carcinoma (ESCA), mesothelioma (MESO) and thyroid carcinoma (THCA). In addition, we identified five genes, KIF2C, KIF23, CDC25, CCNB1 and DLGAP5, whose expression was positively related to KIF20A expression.Conclusions: This pan-cancer study provides a comprehensive understanding of KIF20A's oncogenic functions in a variety of human tumors.
What problem does this paper attempt to address?